Ligand Pharmaceuticals, Inc. (LGND)
ROA
Obliczenia
|
2023 (31 gru 2023) |
2022 (31 gru 2022) |
2021 (31 gru 2021) |
2020 (31 gru 2020) |
2019 (31 gru 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | 52 154 | -33 361 | 57 138 | -2 985 | 629 302 |
| Aktywa razem | w tys. USD | 787 216 | 762 668 | 1 297 590 | 1 362 280 | 1 494 920 |
| ROA | 6,63% | -4,37% | 4,40% | -0,22% | 42,10% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $52 154K ÷ $787 216K
= 6,63%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Ligand Pharmaceuticals, Inc.
LGND
6,63%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Arcus Biosciences Inc
RCUS
-28,04%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Collegium Pharmaceutical Inc
COLL
4,21%
Dynavax Technologies Corp.
DVAX
-0,64%
Innoviva Inc
INVA
14,45%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Medifast Inc
MED
32,08%
Myriad Genetics, Inc.
MYGN
-22,97%
Xencor Inc
XNCR
-13,23%